- $113.35m
- -$35.11m
Annual cashflow statement for PepGen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.3 | -69.1 | -78.6 | -90 | -89.7 |
| Depreciation | |||||
| Non-Cash Items | 1.73 | 4.84 | 6.49 | 11.3 | 12.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.77 | 4.51 | 1.95 | -5.25 | -6.22 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -22.6 | -59.3 | -69 | -82.4 | -81.6 |
| Capital Expenditures | -0.5 | -3.75 | -2.6 | -0.497 | -0.264 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -29.4 | -37.2 | -15 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.5 | -3.75 | -32 | -37.7 | -15.2 |
| Financing Cash Flow Items | -1.39 | -2.7 | -0.442 | 1.97 | -0.121 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 148 | 112 | -0.189 | 88.7 | 108 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 125 | 48.9 | -101 | -31.4 | 11.1 |